These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15451781)

  • 1. Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo.
    Buerkle MA; Lehrer S; Sohn HY; Conzen P; Pohl U; Krötz F
    Circulation; 2004 Oct; 110(14):2053-9. PubMed ID: 15451781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombotic effects of diclofenac on arteriolar platelet activation and thrombosis in vivo.
    Struthmann L; Hellwig N; Pircher J; Sohn HY; Buerkle MA; Klauss V; Mannell H; Pohl U; Krötz F
    J Thromb Haemost; 2009 Oct; 7(10):1727-35. PubMed ID: 19691487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
    Belton OA; Duffy A; Toomey S; Fitzgerald DJ
    Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestogens stimulate prostacyclin production by human endothelial cells.
    Hermenegildo C; Oviedo PJ; García-Martínez MC; García-Pérez MA; Tarín JJ; Cano A
    Hum Reprod; 2005 Jun; 20(6):1554-61. PubMed ID: 15734756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
    Patrignani P; Sciulli MG; Manarini S; Santini G; Cerletti C; Evangelista V
    J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
    Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
    J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
    Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G
    Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation.
    Borgdorff P; Tangelder GJ; Paulus WJ
    J Am Coll Cardiol; 2006 Aug; 48(4):817-23. PubMed ID: 16904555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro.
    Wang MM; Xue M; Xu YG; Miao Y; Kou N; Yang L; Zhang Y; Shi DZ
    Thromb Res; 2016 May; 141():146-52. PubMed ID: 27043068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.
    Dowd NP; Scully M; Adderley SR; Cunningham AJ; Fitzgerald DJ
    J Clin Invest; 2001 Aug; 108(4):585-90. PubMed ID: 11518732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis.
    Tanaka N; Sato T; Fujita H; Morita I
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):607-12. PubMed ID: 14726416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo.
    Giuliano F; Mitchell JA; Warner TD
    J Pharmacol Exp Ther; 2001 Dec; 299(3):894-900. PubMed ID: 11714873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells.
    Mark KS; Trickler WJ; Miller DW
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1051-8. PubMed ID: 11356928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
    Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
    Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.